Overslaan en naar de inhoud gaan

Toxicologie publicaties

Van eigen bodem

  1. Smits TA, Gresnigt FMJ, van Groen BD, Franssen E.J.F., Attema-de Jonge ME. A prospective investigation of the performance of two gamma-hydroxybutyric acid (GHB) tests: DrugCheck GHB Single Test and Viva-EGHB immunoassay. Ther Drug Monit. 2019 Jul 15. doi: 10.1097/FTD.0000000000000677. PubMed PMID: 31318841.
  2. Lidwien P F M van Helmond, Femke M J Gresnigt. Safety of withholding intubation in gamma-hydroxybutyrate- and gamma-butyrolactone-intoxicated coma patients in the emergency department. Eur J Emerg Med. 2020 Jun;27(3):223-227. doi: 10.1097/MEJ.0000000000000649.
  3. van der Pas RSD*, Gresnigt FMJ*, Wansink L, Franssen EJF, Riezebos RK. Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual. Toxicol Rep. 2020 Dec 3;7:1629-1633. doi: 10.1016/j.toxrep.2020.12.003. eCollection 2020.
  4. Van Der Schaar J.A.J., Attema-De Jonge M.E., Gresnigt F.M.J., Franssen E.J.F. Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drug-of-abuse point-of-care test is expanded with GHB and ketamine. Toxicology Reports, Volume 7, 2020, Pages 539-546
  5. Gresnigt FMJ, Gubbels NP, Riezebos RK. The current practice for cocaine-associated chest pain in the Netherlands. Toxicol Rep. 2020 Dec 18;8:23-27. doi: 10.1016/j.toxrep.2020.12.011. eCollection 2021.
  6. T. A. Smits*, F.M.J. Gresnigt*, Dr M.E.  Attema-de Jonge, Dr. E.J.F. Franssen. Can emergency department clinicians diagnose gamma-hydroxybutyrate (GHB) intoxication based on clinical observations alone? Emerg Med J 2021;0:1–4. doi:10.1136/emermed-2020-209577
  7. Philip G. Frankenmolen, Caroline L. Hoogerheide-Wiegerinck, Floor F. van Bakkum, Esther A. Croes, Jasper R. Rebel en Femke M.J. Gresnigt. Complicaties van vervuilde drugs Hoe kunnen we het aantal slachtoffers beperken? NTvG. 2021;165:D5869
  8. Arjen Koppen, Anja P. G. Wijnands-Kleukers, Femke M. J. Gresnigt & Dylan W. de Lange (2022): Clinical toxicology of exposures to chemicals from clandestine drug laboratories: a literature review. Clinical Toxicology, DOI: 10.1080/15563650.2022.2041201
  9. Gresnigt F, Janszen A, Franssen EJF, Lange D, Riezebos RK. Reliability of self-reported recreational drug use in young chest pain patients, a retrospective study. Eur J Emerg Med. 2022 Aug 1;29(4):307-308. doi: 10.1097/MEJ.0000000000000914. Epub 2022 Jun 28. PMID: 35773205 
  10. F.M.J. Gresnigt , P. Ghaem Maghami , P.van Exter,  A. Noordhoff, T van Dijk,  Ronald van Listenburg, F. Holleman, M.H.H. Kramer, P.W.B. Nanayakkara. Recreational drug use during the Amsterdam Dance Event: impact on Emergency Services. Substance Abuse: Research and Treatment 2022;16: 1–6. https://doi.org/10.1177/11782218221114965
  11. Dena Akhoundzadeh, Parisa Kamali, Bas van den Bogaard en Femke M.J. Gresnigt. Invloed van covid-19-pandemie op drugsintoxicaties. NTvG 2022;166:D6546
  12. Gresnigt FMJ, Hulshof M, Franssen EJF, Vanhommerig JW, de Lange DW, Riezebos RK. Recreational drug use among young, hospitalized patients with acute coronary syndrome: A retrospective study. Toxicol Rep. 2022 Nov 8;9:1993-1999. doi: 10.1016/j.toxrep.2022.10.016. PMID: 36518490; PMCID: PMC9742953.
  13. Gresnigt FMJ*, Snik A*, Franssen EJF, Vanhommerig JW, de Lange DW, Riezebos RK. 4-Fluoroamphetamine (4-FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis. J Am Coll Emerg Physicians Open. 2022 Sep 26;3(5):e12813. doi: 10.1002/emp2.12813. PMID: 36187507; PMCID: PMC9512775.
  14. M. van Bemmel, F. Gresnigt, I. Schouten. Post-anoxic encephalopathy after suicide attempt using the helium method. Netherlands Journal of Critical Care. 2023 Jan;31(1):17-19.
  15. Koppen, F.M.J. Gresnigt, P. van Ruyven, M. Nalai, E.F. Schippers. Needle spiking, het drogeren met een injectienaald. Ned Tijdschr Geneeskd. 2023;167:D7140
  16. Femke M.J. Gresnigt, Lianne C. van den Brink, Eric J.F. Franssen, Dylan W. de Lange, Robert K. Riezebos. The incidence of cardiovascular symptoms and adverse events following self-reported cannabis intoxication at the emergency department, a retrospective study. EMJ.
  17. F.M.J. Gresnigt*, E.S. Smits*, C. den Haan, R.K. Riezebos, E.J.F. Franssen, D.W. de Lange. The association of amfetamines and cathinones with acute coronary syndrome – a systematic review. Clin Toxicol (Phila). 2023 May;61(5):336-345. doi: 10.1080/15563650.2023.2191819. Epub 2023 May 12. PMID: 37171152
  18. Dijkman MA, Gresnigt FMJ, de Lange DW. Digoxin-specific antibodies: a novel dosing strategy. Neth Heart J. 2023 Oct 20. doi: 10.1007/s12471-023-01814-y. Online ahead of print. PMID: 37861975
  19. L. Groenewegen*, F.M.J. Gresnigt*, J.J. Nugteren-van Lonkhuyzen, C. den Haan, D. Ohana, E.J.F. Franssen, R.K. Riezebos, D.W. de Lange. Cardiotoxicity after synthetic cathinone use; two cases, a case series and scoping review. Cardiovascular Toxicology. Published online: 27 Feb 2024. https://doi.org/10.1007/s12012-024-09832-x
  20. van Amsterdam, J.; Gresnigt, F.; van den Brink, W. Cardiovascular Risks of Simultaneous Use of Alcohol and Cocaine—A Systematic Review. Clin. Med. 2024, 13(5), 1475. https:// doi.org/10.3390/jcm13051475
  21. Kraaijvanger, W. Raven, T. van Dijken, F. Gresnigt. The PIRATE mnemonic: providing a structured approach in the care for intoxicated patients at the emergency department. International Journal of Emergency Medicine (2024) 17:30 https://doi.org/10.1186/s12245-024-00606-4
  22. F.M.J. Gresnigt, L.K. Heikamp, J.J.W. van Essen, C. Ofwegen, L. Walraven, S. Mollink, E.J.F. Franssen, D.W. de Lange, R.K. Riezebos. The appliance of ESC guidelines for ruling out acute coronary syndrome in low risk patients with cocaine-associated chest pain in the emergency department (RISK study): an observational study. Toxicology Reports 2024
  23. E. Schieveen, F.M.J. Gresnigt, C. den Haan. The use of lipid emulsion therapy in severe hydroxychloroquine overdose – a systematic review of the literature. Clin Toxicol (Phila). 2024 Nov;62(11):677-685
  24. F.M.J. Gresnigt, J.J.W. van Essen, C.C. Hunault, E.J.F. Franssen, D.W. de Lange, R.K. Riezebos. Performance of the modified cocaine HEART score, HEART pathway and traditional HEART score in Patients with Cocaine Associated Chest Pain presenting at the Emergency Department. Clin Toxicol (Phila). 2025 May;63(5):317-324. doi: 10.1080/15563650.2025.2472955. Epub 2025 Apr 14.PMID: 40223607
  25. Zuidema M, Gresnigt F, vd Bogaard B. Case series of ICU admission of MDMA intoxicated patients –Acute complications and treatment in critically ill MDMA-intoxicated patients. Clin Toxicol (Phila). 2025 Mar;63(3):176-182. doi: 10.1080/15563650.2025.2453619. Epub 2025 Feb 20.PMID: 39977237
  26. Joep J.J. Ouwerkerk, David M. Wood, Alison M. Dines, Chris Yates, Florian Eyer, Fridtjof Heyerdahl, Isabelle Giraudon, Knut Erik Hovda, Matthias E. Liechti, Òscar Miró, Odd Martin Vallersnes, Paul I. Dargan, Euro-DEN Plus Research Group, M.J. Gresnigt. Differences in the clinical presentation of acute 3,4-methylenedioxymetamfetamine intoxication by co-intoxication and patient sex to European emergency departments. Clin Toxicol (Phila). 2025 Mar;63(3):183-192. doi: 10.1080/15563650.2025.2453052. Epub 2025 Mar 19.PMID: 40106272
  27. Sabrina Marongiu, Maarten van Eijk, Femke M.J. Gresnigt, Esther A. Croes, Eric J.F. Franssen. Rising incidence of recreational ketamine use: Clinical cases and management in emergency settings. Toxicology Reports Volume 14, June 2025, 101940
  28. Ouwerkerk JJJ, Gresnigt FMJ, Lijmer JG, Kraaijvanger. Assessing agitation, preventing escalation. Reflecties op (non)-verbale de-escalatie en farmacologische interventies. Ned Tijdschr Geneeskd. 2025 Sep 11;169:D8516.PMID: 40928434 Dutch.
  29. F.M.J.Gresnigt, E.J.F. Franssen, D.W. de Lange, R.K. Riezebos. De patiënt met acute cardiovasculaire klachten na drugsgebruik. Ned Tijdschr Geneeskd. 2025;169:D8569
  30. Graafsma J, Cimic N, Dijkman M, Gresnigt FMJ, Mitrovic D, Smit C. Digoxin toxicity with therapeutic serum digoxin concentrations. Toxicol Rep. 2025 Jul 5;15:102079. doi: 10.1016/j.toxrep.2025.102079. eCollection 2025 Dec.PMID: 40687894
  31. Frantzen MGM, Gresnigt FMJ, Litsenburg van RTH and Franssen EJF, Clinical evaluation of oral fluid Point-of-Care testing for drugs of abuse compared to urinary Point-of-Care testing at a large-scale music festival, Toxicology Reports, (2025) doi:https://doi.org/10.1016/j.toxrep.2025.102192